euro adhoc: Intercell AG / Financial Figures/Balance Sheet / Approvals for...
——————————————————————————– Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ——————————————————————————– 9-month report 11.11.2008...
View ArticleMediGene setzt Fokussierung durch interne Umstrukturierung weiter fort
(pressebox) Martinsried/München, 28.09.2009, . – Umschichtung personeller und finanzieller Ressourcen auf klinische Entwicklung – Langfristig positiver Einfluss auf Barmittelverbrauch Das...
View ArticleEANS-Adhoc: Intercell AG Announces Q3 2009 Results and Updates on R&D...
——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement....
View ArticleAbbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
ABBOTT PARK, Illinois and REDWOOD CITY, California, March 9, 2010 (ots/PRNewswire) — Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing...
View ArticleAlgorithme Pharma Announces a Strategic Appointment
Laval, Canada, May 12, 2010 (ots/PRNewswire) – Doug Peel, Executive Chairman of the Board of Directors of Algorithme Pharma, is pleased to announce the appointment of Christopher Perkin as the...
View ArticleGW Announces UK Launch of World’s First Prescription Cannabis Medicine
Porton Down, England, June 21, 2010 (ots/PRNewswire) – GW Pharmaceuticals plc (GWP:AIM) today announces the UK launch of Sativex(R), its Oromucosal Spray for the treatment of spasticity due to Multiple...
View ArticleEANS-Adhoc: Intercell AG announces Q3 2010 results and updates on R&D...
——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement....
View ArticleJanssen Submits European Marketing Authorisation Application for...
Beerse, Belgium (ots/PRNewswire) – Janssen-Cilag International NV (Janssen) announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for...
View ArticleBiocartis Announces Commercial Launch of a New Biomarker Analysis Platform
Lausanne, Switzerland (ots/PRNewswire) – Biocartis launches its revolutionary detection platform, Dynamic Multi-Analyte Technology (“DMAT”): – New proteomic and nucleic acid platform provides...
View ArticleJanssen R&D Ireland Announces Agreement with PATH for Early Development of...
Cork, Ireland (ots/PRNewswire) – Janssen R&D Ireland (Janssen) announced today it has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1...
View Article
